Eli Lilly and Co. and Purdue University announce a $250 million investment to continue to accelerate pharmaceutical innovation and boost Indiana's economy.

U.S. pharmaceutical companies are increasingly licensing new drugs from China. Former FDA Commissioner Scott Gottlieb ...

The U.S. Food and Drug Administration said on Thursday it plans to replace animal testing in the development of monoclonal ...

It’s not uncommon for drug development processes to take more ... Get inside access to Europe’s top investment minds — with leaders from Monzo, Accel, Paladin Group, and more — plus ...

M42 and Juvenescence will collaborate in drug discovery to develop a pipeline of innovative medicines to advance the ...

Unfortunately, biotech has been in a brutal run of its own: ...

Metsera is a new GLP-1 player with a Phase 2b injectable and promising oral and amylin drugs in development. Learn why MTSR ...

The inaugural Taiwan-Japan Investment and Industry Networking Event took place at the Global Life Science Hub in Tokyo. The ...

New research from Bayes Business School, in collaboration with biopharmaceuticals company Merck KGaA, suggests member states ...